Year: 2026
Type: article
Abstract: Formulation development is a fundamental component of pharmaceutical science that involves designing and optimizing a dosage form to ensure the safety, efficacy, stability, quality, and acceptable performance of a drug product. It bridges pharmaceutical research and commercial manufacturing by integrating knowledge of pharmaceutics, pharmaceutical technology, biopharmaceutics, analytical chemistry, and regulatory science. The process includes preformulation studies, excipient selection, dosage-form design, optimization of formulation variables, manufacturing-process development, quality evaluation, stability testing, and scale-up. Modern formulation development increasingly incorporates Quality by Design (QbD), risk assessment, design of experiments (DoE), nanotechnology, and advanced drug-delivery systems to improve therapeutic outcomes and manufacturing consistency. Challenges such as poor aqueous solubility, inadequate bioavailability, drug– excipient incompatibility, stability problems, and manufacturing variability require systematic scientific investigation. This review discusses the major stages of pharmaceutical formulation development, commonly used dosage forms, evaluation parameters, regulatory considerations, recent technological advances, and future perspectives. A systematic and patient-centred formulation strategy can support the development of reliable, effective, and high-quality medicines.
Language: English
Subfield: Pharmaceutical Science
Domain: Life Sciences
Keywords: drug formulation development, dosage form development, preformulation, excipient selection, quality by design, experimental design, nanotechnology drug delivery, drug stability testing, scale-up, drug-excipient incompatibility, bioavailability, regulatory considerations, manufacturing variability
Open Access status: diamond
OpenAlex ID: W7234463483
